Glycolipids and synthetic method thereof as well as their...

Details Glycolipids and synthetic method thereof as well as their... Glycolipids and synthetic method thereof as well as their...

2010-04-15

2011-10-11

Bland, Layla (Department: 1623)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C552S010000, C514S025000

Reexamination Certificate

active

08034908

ABSTRACT:
Novel glycolipid derivatives, where the substituent of the sphingosine base part is a short carbon chain alkyl group, substituted or unsubstituted cycloalkyl group, substituted or unsubstituted aryl group or substituted or unsubstituted aralkyl group and efficient synthetic methods for practical mass production of the same and intermediates useful for the synthesis of these compounds.Glycolipids having the formula (I):where R3indicates a substituted or unsubstituted C1to C7linear alkyl group, substituted or unsubstituted cycloalkyl group, substituted or unsubstituted aryl group, or substituted or unsubstituted aralkyl group and R8indicates a substituted or unsubstituted C1to C35alkyl group, substituted or unsubstituted aryl group or substituted or unsubstituted aralkyl group are chemically synthesized.

REFERENCES:
patent: 5849716 (1998-12-01), Akimoto et al.
patent: 5936076 (1999-08-01), Higa et al.
patent: 0 609 437 (1994-08-01), None
patent: 0 666 268 (1995-08-01), None
patent: 0 988 860 (2000-03-01), None
patent: 93/05055 (1993-03-01), None
patent: 94/09020 (1994-04-01), None
patent: WO 98/16235 (1998-04-01), None
patent: 03/016326 (2003-02-01), None
Khankari et al. Thermochimica Acta 248 (1995) 61-79.
Miyamoto, K. et al., “A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells”, Nature, Oct. 4, 2001, vol. 413, No. 6855, pp. 531-534.
Miyake, S. “NKT Saibo to Jikkenteki Jikio Men'ekisei No Sekizuien”, Inflammation & Immunology, Aug. 20, 2002, vol. 10, No. 5, pp. 501-506.
Miyake, S. “NKT Saibo Toshishitsu Ligand ni yoru Jiko Men'ekisei Shikkan Seigo”, Annual Review Men'eki 2003, Dec. 5, 2002, pp. 71-77.
Ayad, T et al., “A new diorganiozinc-based enantio-selective access to truncated D-ribo-phytosphingosine”, Tetrahedron Letters, Jan. 13, 2003, vol. 44, Issue 3, pp. 579-582.
Morita, M. et al., “Structure-Activity Relationship of α-Galactosylceramides against B16-Bearing Mice”, Journal of Medicinal Chemistry, Jun. 9, 1995, vol. 38, No. 12, pp. 2176-2187.
Brossay, L. et al., “Cutting Edge: Structural Requirements for Galactosylceramide Recognition by CDI-Restricted NK T Cells”, Journal of Immunology, Nov. 15, 1998, vol. 161, No. 10, pp. 5124-5128.
Chiu, H., et al., “A Facile Synthesis of Phyto-sphingosine from Diisopropylidene-D-mannofuranose”, Journal of Organic Chemistry, Jul. 11, 2003, vol. 68, No. 14, pp. 5788-5791.
Kawano, T. et al., “Natural killer-like non-specific tumor cell lysis medicated by specific ligand-activated Vα14 NKT cells”, Proceedings of the Natural Academy of Sciences of the USA, May 12, 1998, vol. 95, No. 10, pp. 5690-5693.
Kidd, P. PhD., Th1/Th2 Balance: The Hypothesis, its Limitations, and Implications for Health and Disease,: Alternative Medicine Review, vol. 8, No. 3, 2003, pp. 223-246.
Yamamura, Takashi, “Notoshinkei,” vol. 53, 2001, pp. 707-713.
Figueroa-Perez et al. Carbohydrate Research 328 (2000) 95-102.
Wild et al. Liebigs Ann. 1995, 755-764.
Schmidt et al. Carbohydrate Research vol. 174, Mar. 15, 1988, abstract.
Kobayashi et al. Tetrahedron Letters, vol. 35, No. 51, pp. 9573-9576.
Murata et al., “Total Synthesis of an Immunosuppressive Glycolipid, (2S,3S,4R)-1-O-(α-D-Galactosyl)-2- tetracosanoylamino-1,3,4-nonanetroil”,J. Org. Chem., vol. 70, No. 6, 2005, pp. 2398-2401.
Costantino et al., “Immunomodulating Glycophingolipids: an Efficient Synthesis of a 2′-deoxy-α-galactosyl-GSL”,Tetrahedron, Elsevier Science Publishers, Amsterdam, NL, vol. 58, No. 2, Jan. 7, 2002, pp. 369-375, XP004330613.
Akimoto et al., “Synthesis and Stereochemistry of Agelasphin-9b”,Tetrahedron Letters, vol. 34, No. 35, 1993, pp. 5593-5596, XP002554487.
Schmidt et al., “Synthesis ofD-ribo-ANDL-lyxo-Phytosphingosine: Transformation Into the Corresponding Lactosyl-Ceramides”,Carbohydrae Research, Elsevier Science Publishers B. V., Amsterdam, vol. 174, 1998, pp. 169-179, XP002554488.
Plettenburg et al., “Synthesis of α-Galactosyl Ceramide, A Potent Immunostimulatory Agent”,J. Org. Chem., vol. 67, No. 13, 2002, pp. 4559-4564, XP002554489.
Toshima et al., Chem. Rev. 1993, 93, 1503-1531.
Search Report for PCT/JP2004/001566.
European Office Action dated Jun. 14, 2011 in European Patent Application No. 11160814.7.

Affiliated with

Also associated with

Rating

Glycolipids and synthetic method thereof as well as their... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glycolipids and synthetic method thereof as well as their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycolipids and synthetic method thereof as well as their... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4256660